Showing results (11-20 of 276) with videos related to
Sort By:
Pageof 28
Cell Metabolism|June 2, 2026
Is an emerging pharmacotherapeutic era for rare mitochondrial diseases here?Jirair K Bedoyan, Jerry VockleyDrugs|March 14, 2019
Phenylketonuria: Current Treatments and Future DevelopmentsUta Lichter-Konecki, Jerry VockleyPediatric Clinics of North America|March 6, 2018
Inborn Errors of Metabolism with Myopathy: Defects of Fatty Acid Oxidation and the Carnitine Shuttle SystemAreeg El-Gharbawy, Jerry VockleyClinical Therapeutics|August 4, 2022
Survey of Health Care Provider Understanding of Gene Therapy Research for Inherited Metabolic DisordersJoyanna Hansen, Radha Ramachandran, Jerry VockleyNeuromuscular Disorders : NMD|January 22, 2002
Defects of mitochondrial beta-oxidation: a growing group of disordersJerry Vockley, David A H WhitemanBiochimie|December 3, 2014
Kinetic and spectral properties of isovaleryl-CoA dehydrogenase and interaction with ligandsAl-Walid A Mohsen, Jerry VockleyMolecular Genetics and Metabolism|January 1, 2010
Clinical trials: curing a critical deficiency in metabolic medicineJerry Vockley, Catherine M Walsh VockleyJournal of Pediatric Gastroenterology and Nutrition|January 13, 2016
Possible Phenylacetate Hepatotoxicity During 4-Phenylbutyrate Therapy of Byler DiseaseBenjamin L Shneider, Amy Morris, Jerry VockleyMolecular Genetics and Metabolism|May 18, 2005
In vitro correction of medium chain acyl CoA dehydrogenase deficiency with a recombinant adenoviral vectorDavid B Schowalter, Dietrich Matern, Jerry VockleyGenetics in Medicine : Official Journal of the American College of Medical Genetics|January 26, 2021
Impact of newborn screening on the reported incidence and clinical outcomes associated with medium- and long-chain fatty acid oxidation disordersDeborah Marsden, Camille L Bedrosian, Jerry VockleyPageof 28